Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 30, 2020 04:00 ET | Source: Zealand Pharma

Total number of shares and voting rights in Zealand Pharma at September 30, 2020

Company announcement – No. 51 / 2020 Copenhagen, September 30, 2020 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no. 20 04 50 78), a Copenhagen-based biotechnology company focused on the...
September 22, 2020 08:17 ET | Source: Zealand Pharma

Correction: Zealand Pharma announces amendments to its Articles of Association following the granting of warrants

Company announcement – No. 50 / 2020 Correction: Zealand Pharma announces amendments to its Articles of Association following the granting of warrants Copenhagen, September 22, 2020 – Zealand...
September 18, 2020 07:00 ET | Source: Zealand Pharma

Zealand Pharma announces amendments to its Articles of Association following the granting of warrants

Company announcement – No. 50 / 2020 Zealand Pharma announces amendments to its Articles of Association following the granting of warrants Copenhagen, September 18, 2020 – Zealand Pharma A/S...
September 14, 2020 10:13 ET | Source: Zealand Pharma

Zealand Pharma grants warrants and restricted share units under the employee warrant program and management long-term incentive program

Company announcement – No. 49 / 2020 Zealand Pharma grants warrants and restricted share units under the employee warrant program and management long-term incentive program Copenhagen, September 14,...
September 11, 2020 10:00 ET | Source: Zealand Pharma

Zealand Pharma increases its share capital as a consequence of exercise of employee warrants

Company announcement – No. 48 / 2020 Zealand Pharma increases its share capital as a consequence of exercise of employee warrants Copenhagen, September 11, 2020 – Zealand Pharma A/S (“Zealand”)...
September 04, 2020 06:00 ET | Source: Zealand Pharma

Zealand Pharma builds Global Medical Affairs function with world-renowned experts

Press release – No. 47 / 2020 Zealand Pharma builds Global Medical Affairs function with world-renowned experts Dr. Danilo Verge and Dr. David Kendall, both of whom have decades of experience in the...
September 03, 2020 04:00 ET | Source: Zealand Pharma

Zealand Pharma to participate in upcoming investor conferences

Press Release – No. 46 / 2020 Zealand Pharma to participate in upcoming investor conferences Copenhagen, DK September 3, 2020 – Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no. 20045078), a biotechnology...
August 31, 2020 10:00 ET | Source: Zealand Pharma

Total number of shares and voting rights in Zealand Pharma at August 31, 2020

Company announcement – No. 45 / 2020 Total number of shares and voting rights in Zealand Pharma at August 31, 2020 Copenhagen, August 31, 2020 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL)...
August 21, 2020 07:15 ET | Source: Zealand Pharma

Zealand Pharma increases its share capital as a consequence of exercise of employee warrants

Company announcement – No. 44 / 2020 Zealand Pharma increases its share capital as a consequence of exercise of employee warrants Copenhagen, August 21, 2020 – Zealand Pharma A/S (“Zealand”)...
August 13, 2020 09:00 ET | Source: Zealand Pharma

Zealand Pharma announces acceleration of U.S. commercial operations through the completion of the Valeritas acquisition; FDA acceptance of New Drug Application submission for the dasiglucagon HypoPal® rescue pen; pipeline progress including

Interim report for H1 2020 Zealand Pharma announces acceleration of U.S. commercial operations through the completion of the Valeritas acquisition; FDA acceptance of New Drug Application...